Skip to main content
. 2021 Aug 10;12:699466. doi: 10.3389/fphar.2021.699466

FIGURE 4.

FIGURE 4

OMP registries and EMA regulatory pathways. A, appropriateness; OMP, orphan medicinal product; PbR, payment by result; FbA, fincial-based agreement; PaR, payment at result.